WSR is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is essentially trading at the $19 acquisition price, leaving little to no upside from here. Given the lack of a stronger takeover bid, muted recent news, and analyst downgrades to Neutral/Hold around the deal price, the risk-reward is unattractive for someone who wants a straightforward long-term investment and does not want to wait for a better entry.
Technically, WSR is flat near its pivot at 18.99 with a current price of 19.01. The moving average structure is still bullish on a short-to-long basis (SMA_5 > SMA_20 > SMA_200), but momentum is weakening: MACD histogram is negative at -0.0668 and contracting. RSI_6 at 74.161 suggests the stock is stretched/overextended rather than offering an attractive fresh entry. Support and resistance are tightly clustered around the current price, which also points to limited upside. Overall, the chart shows a mature move with poor near-term reward potential.

["There is an announced all-cash acquisition by Ares Management at $19 per share, which provides a clear reference price and near-term downside floor around that level.", "Analysts broadly agree the process has likely capped downside and created a near-certain exit value near $19."]
["The stock is already trading essentially at the deal price, so upside appears capped.", "Recent news flow is absent; no fresh catalysts emerged in the last week.", "Several analysts downgraded the stock to Neutral/Hold/Market Perform after the acquisition announcement, indicating limited incremental upside.", "Stock-trend modeling suggests a meaningful probability of negative performance over the next day, week, and month.", "No recent insider buying, hedge fund accumulation, or congress trading activity is visible."]
No usable latest-quarter financial snapshot was provided, so I cannot assess the most recent quarter’s revenue or earnings growth trends. As a result, the decision is driven mainly by deal dynamics, technicals, and sentiment rather than fundamentals.
Recent analyst action has turned mostly cautious: B. Riley, Cantor Fitzgerald, Colliers, Citizens, and Truist all moved to Neutral/Hold/Market Perform after the Ares acquisition at $19 per share. The Wall Street view is basically that the deal price is fair and that there is limited room for a competing bid, which means the upside case is weak and the pros and cons both center on the acquisition completing rather than the business re-rating higher.